CCL2 and cancer: There have been abundant reports demonstrating that metformin diminishes NF-κB, inhibiting inflammatory responses34, cancer stem cell proliferation and transformation37, and the expression of adhesion molecular genes such as VCAM-1, ICAM-1, E-Selectin, and MCP-1 in endothelial cells39.